{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T04:03:50Z","timestamp":1767585830593},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of weak acids with pH values in the range of 4\u20137 has been implicated in the symptoms of gastroesophageal reflux disease (GERD). Prostaglandin E<jats:sub>2<\/jats:sub> (PGE<jats:sub>2<\/jats:sub>) is associated with heartburn symptom in GERD patients; however, the precise productive mechanisms remain unclear. In this study, we revealed that exposure to weak acids increases PGE<jats:sub>2<\/jats:sub> production with a peak at pH 4\u20135, slightly in human normal oesophageal cells (Het-1A), and robustly in oesophageal squamous carcinoma cells (KYSE-270). Release of PGE<jats:sub>2<\/jats:sub> from the oesophageal mucosa was augmented by weak acid treatment in rat. Chenodeoxycholic acid (CDCA), a bile acid, upregulated cyclooxygenase-2 (COX-2) expression in Het-1A and KYSE-270 and induced PGE<jats:sub>2<\/jats:sub> production in KYSE-270 cells. Weak acid-induced PGE<jats:sub>2<\/jats:sub> production was significantly inhibited by cytosolic phospholipase A2 (cPLA2), ERK, and transient receptor potential cation channel subfamily V member 4 (TRPV4), a pH-sensing ion channel, inhibitors. Hangeshashinto, a potent inhibitor of COX-2, strongly decreased weak acid- and CDCA-induced PGE<jats:sub>2<\/jats:sub> levels in KYSE-270. These results indicated that weak acids induce PGE<jats:sub>2<\/jats:sub> production via TRPV4\/ERK\/cPLA2 in oesophageal epithelial cells, suggesting a role in GERD symptoms like heartburn. Interventions targeting pH values up to 5 may be necessary for the treatment of GERD.<\/jats:p>","DOI":"10.1038\/s41598-020-77495-z","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T11:03:24Z","timestamp":1606475004000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Weak acids induce PGE2 production in human oesophageal cells: novel mechanisms underlying GERD symptoms"],"prefix":"10.1038","volume":"10","author":[{"given":"Daichi","family":"Sadatomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Mogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Fujitsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"77495_CR1","first-page":"211","volume":"115","author":"DE Bujanda","year":"2018","unstructured":"Bujanda, D. E. & Hachem, C. Barrett\u2019s esophagus. Mol. Medl 115, 211\u2013213 (2018).","journal-title":"Mol. Medl"},{"key":"77495_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.gastro.2019.03.072","volume":"157","author":"J Que","year":"2019","unstructured":"Que, J., Garman, K. S., Souza, R. F. & Spechler, S. J. Pathogenesis and cells of origin of Barrett\u2019s esophagus. Gastroenterology 157, 349\u2013364 (2019).","journal-title":"Gastroenterology"},{"key":"77495_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/gut.28.9.1145","volume":"28","author":"F Johnsson","year":"1987","unstructured":"Johnsson, F., Joelsson, B. & Isberg, P. E. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 28, 1145\u20131150 (1987).","journal-title":"Gut"},{"key":"77495_CR4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1053\/gast.1996.1101982","volume":"110","author":"PJ Kahrilas","year":"1996","unstructured":"Kahrilas, P. J. & Quigley, E. M. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 110, 1982\u20131996 (1996).","journal-title":"Gastroenterology"},{"key":"77495_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gut.2003.033290","volume":"53","author":"D Sifrim","year":"2004","unstructured":"Sifrim, D., Castell, D., Dent, J. & Kahrilas, P. J. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53, 1024\u20131031 (2004).","journal-title":"Gut"},{"key":"77495_CR6","first-page":"325","volume":"62","author":"LF Johnson","year":"1974","unstructured":"Johnson, L. F. & Demeester, T. R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am. J. Gastroenterol. 62, 325\u2013332 (1974).","journal-title":"Am. J. Gastroenterol."},{"key":"77495_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1442-2050.2010.01100.x","volume":"24","author":"V Namasivayam","year":"2011","unstructured":"Namasivayam, V., Arora, A. S. & Murray, J. A. Weakly acidic reflux. Dis. Esophagus 24, 56\u201362 (2011).","journal-title":"Dis. Esophagus"},{"key":"77495_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/nyas.13169","volume":"1380","author":"N de Bortoli","year":"2016","unstructured":"de Bortoli, N. et al. Between GERD and NERD: the relevance of weakly acidic reflux. Ann. N. Y. Acad. Sci. 1380, 218\u2013229 (2016).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"77495_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gut.2007.133470","volume":"57","author":"F Zerbib","year":"2008","unstructured":"Zerbib, F., Duriez, A., Roman, S., Capdepont, M. & Mion, F. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 57, 156\u2013160 (2008).","journal-title":"Gut"},{"key":"77495_CR10","doi-asserted-by":"publisher","DOI":"10.1159\/000500133","author":"Y Abe","year":"2019","unstructured":"Abe, Y. et al. Influence of the pH value of refluxate and proximal extent on heartburn perception in patients with proton pump inhibitor-refractory non-erosive reflux disease. Digestion https:\/\/doi.org\/10.1159\/000500133 (2019).","journal-title":"Digestion"},{"key":"77495_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dote.12284","volume":"29","author":"N de Bortoli","year":"2016","unstructured":"de Bortoli, N. et al. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure. Dis. Esophagus 29, 3\u20139 (2016).","journal-title":"Dis. Esophagus"},{"key":"77495_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrgastro.2016.50","volume":"13","author":"E Scarpellini","year":"2016","unstructured":"Scarpellini, E. et al. Management of refractory typical GERD symptoms. Nat. Rev. Gastroenterol. Hepatol. 13, 281\u2013294 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77495_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(18)31388-6","volume":"392","author":"JAZ Jankowski","year":"2018","unstructured":"Jankowski, J. A. Z. et al. Esomeprazole and aspirin in Barrett\u2019s oesophagus (AspECT): a randomised factorial trial. The Lancet 392, 400\u2013408 (2018).","journal-title":"The Lancet"},{"key":"77495_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.cgh.2015.01.014","volume":"13","author":"T Kondo","year":"2015","unstructured":"Kondo, T. et al. The nonsteroidal anti-inflammatory drug diclofenac reduces acid-induced heartburn symptoms in healthy volunteers. Clin. Gastroenterol. Hepatol. 13, 1249\u20131255 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77495_CR15","doi-asserted-by":"publisher","first-page":"G568","DOI":"10.1152\/ajpgi.00276.2012","volume":"304","author":"T Kondo","year":"2013","unstructured":"Kondo, T. et al. Prostaglandin E(2) mediates acid-induced heartburn in healthy volunteers. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G568-573 (2013).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"77495_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ijc.21917","volume":"119","author":"T Soma","year":"2006","unstructured":"Soma, T. et al. Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: a possible mechanism of angiogenesis in patients with esophageal cancer. Int. J. Cancer 119, 771\u2013782 (2006).","journal-title":"Int. J. Cancer"},{"key":"77495_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/1471-2407-9-190","volume":"9","author":"E Looby","year":"2009","unstructured":"Looby, E. et al. Deoxycholate induces COX-2 expression via Erk1\/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer 9, 190 (2009).","journal-title":"BMC Cancer"},{"key":"77495_CR18","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1074\/jbc.273.4.2424","volume":"273","author":"F Zhang","year":"1998","unstructured":"Zhang, F., Subbaramaiah, K., Altorki, N. & Dannenberg, A. J. Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J. Biol. Chem. 273, 2424\u20132428 (1998).","journal-title":"J. Biol. Chem."},{"key":"77495_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01588-4","author":"T Takeuchi","year":"2019","unstructured":"Takeuchi, T. et al. Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors\u202f: Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study. J. Gastroenterol. https:\/\/doi.org\/10.1007\/s00535-019-01588-4 (2019).","journal-title":"J. Gastroenterol."},{"key":"77495_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1006\/bbrc.2001.5400","volume":"286","author":"T Kan","year":"2001","unstructured":"Kan, T. et al. Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem. Biophys. Res. Commun. 286, 792\u2013801 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77495_CR21","doi-asserted-by":"publisher","first-page":"13680","DOI":"10.1074\/jbc.M211570200","volume":"278","author":"F Berenbaum","year":"2003","unstructured":"Berenbaum, F., Humbert, L., Bereziat, G. & Thirion, S. Concomitant recruitment of ERK1\/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes. J. Biol. Chem. 278, 13680\u201313687 (2003).","journal-title":"J. Biol. Chem."},{"key":"77495_CR22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1248\/bpb.27.1168","volume":"27","author":"T Hirabayashi","year":"2004","unstructured":"Hirabayashi, T., Murayama, T. & Shimizu, T. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol. Pharm. Bull. 27, 1168\u20131173 (2004).","journal-title":"Biol. Pharm. Bull."},{"key":"77495_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.bcp.2004.05.031","volume":"68","author":"KS Chun","year":"2004","unstructured":"Chun, K. S. & Surh, Y. J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68, 1089\u20131100 (2004).","journal-title":"Biochem. Pharmacol."},{"key":"77495_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/0092-8674(91)90556-E","volume":"65","author":"JD Clark","year":"1991","unstructured":"Clark, J. D. et al. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65, 1043\u20131051 (1991).","journal-title":"Cell"},{"key":"77495_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000343896","volume":"87","author":"T Miyashita","year":"2013","unstructured":"Miyashita, T. et al. Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models. Digestion 87, 6\u201311 (2013).","journal-title":"Digestion"},{"key":"77495_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00535-017-1308-3","volume":"52","author":"T Kondo","year":"2017","unstructured":"Kondo, T. et al. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J. Gastroenterol. 52, 1081\u20131089 (2017).","journal-title":"J. Gastroenterol."},{"key":"77495_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/0016-5085(89)90890-1","volume":"96","author":"JL Smith","year":"1989","unstructured":"Smith, J. L., Opekun, A. R., Larkai, E. & Graham, D. Y. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 96, 683\u2013689 (1989).","journal-title":"Gastroenterology"},{"key":"77495_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00365520600887828","volume":"42","author":"R Fossmark","year":"2007","unstructured":"Fossmark, R., Brenna, E. & Waldum, H. L. pH 4.0. Scand. J. Gastroenterol. 42, 297\u2013298 (2007).","journal-title":"Scand. J. Gastroenterol."},{"key":"77495_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough, A. et al. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30, 377\u2013386 (2009).","journal-title":"Carcinogenesis"},{"key":"77495_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/cncr.32010","volume":"125","author":"GP Nagaraju","year":"2019","unstructured":"Nagaraju, G. P. & El-Rayes, B. F. Cyclooxygenase-2 in gastrointestinal malignancies. Cancer 125, 1221\u20131227 (2019).","journal-title":"Cancer"},{"key":"77495_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0092-8674(93)90666-E","volume":"72","author":"L-L Lin","year":"1993","unstructured":"Lin, L.-L. et al. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269\u2013278 (1993).","journal-title":"Cell"},{"key":"77495_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/CEG.S121056","volume":"11","author":"J Mermelstein","year":"2018","unstructured":"Mermelstein, J., Chait Mermelstein, A. & Chait, M. M. Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions. Clin. Exp. Gastroenterol. 11, 119\u2013134 (2018).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"77495_CR33","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1113\/jphysiol.2011.207829","volume":"589","author":"H Mihara","year":"2011","unstructured":"Mihara, H., Boudaka, A., Sugiyama, T., Moriyama, Y. & Tominaga, M. Transient receptor potential vanilloid 4 (TRPV4)-dependent calcium influx and ATP release in mouse oesophageal keratinocytes. J. Physiol. 589, 3471\u20133482 (2011).","journal-title":"J. Physiol."},{"key":"77495_CR34","doi-asserted-by":"publisher","first-page":"G138","DOI":"10.1152\/ajpgi.00511.2010","volume":"301","author":"T Ueda","year":"2011","unstructured":"Ueda, T., Shikano, M., Kamiya, T., Joh, T. & Ugawa, S. The TRPV4 channel is a novel regulator of intracellular Ca2+ in human esophageal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G138-147 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"77495_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ceca.2019.03.010","volume":"80","author":"M Glitsch","year":"2019","unstructured":"Glitsch, M. Mechano- and pH-sensing convergence on Ca(2+)-mobilising proteins: a recipe for cancer?. Cell Calcium 80, 38\u201345 (2019).","journal-title":"Cell Calcium"},{"key":"77495_CR36","doi-asserted-by":"publisher","first-page":"22664","DOI":"10.1074\/jbc.M302561200","volume":"278","author":"M Suzuki","year":"2003","unstructured":"Suzuki, M., Mizuno, A., Kodaira, K. & Imai, M. Impaired pressure sensation in mice lacking TRPV4. J. Biol. Chem. 278, 22664\u201322668 (2003).","journal-title":"J. Biol. Chem."},{"key":"77495_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1365-2982.2010.01514.x","volume":"22","author":"MP Guarino","year":"2010","unstructured":"Guarino, M. P. et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol. Motil. 22, 746\u2013751 (2010).","journal-title":"Neurogastroenterol. Motil."},{"key":"77495_CR38","doi-asserted-by":"publisher","first-page":"G695","DOI":"10.1152\/ajpgi.00162.2015","volume":"309","author":"L Wu","year":"2015","unstructured":"Wu, L. et al. PAR-2 activation enhances weak acid-induced ATP release through TRPV1 and ASIC sensitization in human esophageal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 309, G695-702 (2015).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"77495_CR39","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2174\/138161212803216924","volume":"18","author":"Y Uezono","year":"2012","unstructured":"Uezono, Y. et al. A review of traditional Japanese medicines and their potential mechanism of action. Curr. Pharm. Des. 18, 4839\u20134853 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"77495_CR40","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.7150\/jca.24733","volume":"9","author":"K Nishikawa","year":"2018","unstructured":"Nishikawa, K. et al. The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C). J. Cancer 9, 1725\u20131730 (2018).","journal-title":"J. Cancer"},{"key":"77495_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-015-2767-y","volume":"76","author":"C Matsuda","year":"2015","unstructured":"Matsuda, C. et al. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis. Cancer Chemother. Pharmacol. 76, 97\u2013103 (2015).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"77495_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/1534735413520035","volume":"13","author":"T Kono","year":"2014","unstructured":"Kono, T. et al. Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes. Integr. Cancer Ther. 13, 435\u2013445 (2014).","journal-title":"Integr. Cancer Ther."},{"key":"77495_CR43","first-page":"232","volume":"1","author":"T Kono","year":"2010","unstructured":"Kono, T. et al. Topical application of hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis. World J. Oncol. 1, 232\u2013235 (2010).","journal-title":"World J. Oncol."},{"key":"77495_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1248\/bpb.20.954","volume":"20","author":"Y Kase","year":"1997","unstructured":"Kase, Y., Hayakawa, T., Ishige, A., Aburada, M. & Komatsu, Y. The effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats. Biol. Pharm. Bull. 20, 954\u2013957 (1997).","journal-title":"Biol. Pharm. Bull."},{"key":"77495_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.02.003","author":"T Miyashita","year":"2018","unstructured":"Miyashita, T. et al. Preventive effect of oral hangeshashinto (TJ-14) on the development of reflux-induced esophageal cancer. Surgery https:\/\/doi.org\/10.1016\/j.surg.2018.02.003 (2018).","journal-title":"Surgery"},{"key":"77495_CR46","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1248\/bpb.21.1277","volume":"21","author":"Y Kase","year":"1998","unstructured":"Kase, Y., Saitoh, K., Ishige, A. & Komatsu, Y. Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels. Biol. Pharm. Bull. 21, 1277\u20131281 (1998).","journal-title":"Biol. Pharm. Bull."},{"key":"77495_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.fitote.2010.09.004","volume":"82","author":"RB van Breemen","year":"2011","unstructured":"van Breemen, R. B., Tao, Y. & Li, W. Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale). Fitoterapia 82, 38\u201343 (2011).","journal-title":"Fitoterapia"},{"key":"77495_CR48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/bioo.2001.1208","volume":"29","author":"E Tjendraputra","year":"2001","unstructured":"Tjendraputra, E., Tran, V. H., Liu-Brennan, D., Roufogalis, B. D. & Duke, C. C. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg. Chem. 29, 156\u2013163 (2001).","journal-title":"Bioorg. Chem."},{"key":"77495_CR49","doi-asserted-by":"publisher","first-page":"532594","DOI":"10.1155\/2014\/532594","volume":"2014","author":"K Takeuchi","year":"2014","unstructured":"Takeuchi, K. & Nagahama, K. Animal model of acid-reflux esophagitis: pathogenic roles of acid\/pepsin, prostaglandins, and amino acids. Biomed. Res. Int. 2014, 532594 (2014).","journal-title":"Biomed. Res. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77495-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:01:49Z","timestamp":1670371309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77495"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77495-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by Tsumura & Co. D.S., S.M., and N.F. are employees of Tsumura & Co.; T.K. received grant support from Tsumura & Co.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20775"}}